ICBP90 mediates Notch signaling to facilitate human hepatocellular carcinoma growth.

Published on Oct 1, 2018in Tissue & Cell1.837
· DOI :10.1016/J.TICE.2018.08.004
Haifeng Fu1
Estimated H-index: 1
(JNU: Jinan University),
Feiyue Xing12
Estimated H-index: 12
(JNU: Jinan University)
+ 3 AuthorsJing Liu8
Estimated H-index: 8
(JNU: Jinan University)
Source
Abstract
Abstract The Notch signaling pathway plays a key role in cell proliferation and development that is closely related to an inverted CCAAT box binding protein (ICBP90), but little is known about whether there is a correlation between Notch signaling and ICBP90. The aim of the current study was to elucidate this. MTT assay and flow cytometry were used to determine the proliferation, cell cycle and apoptosis of HepG2 or Hepa1-6 cells treated by N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT), a specific inhibitor of the Notch pathway. RT-PCR, Western Blot and in situ immunofluorescence staining were employed to examine expression of ICBP90 in the cells. DAPT caused inhibition of the activation of the Notch signaling pathway, followed by preventing the cells at the G0/G1 phases to enter S and G2/M phases. ICBP90 and Hes-1 proteins were highly expressed in the untreated cells. The reduced levels of Notch intracellular domain (NICD) protein were observed in the DAPT-treated cells, thereby bringing about the down-regulation of ICBP90 with the increment of the DAPT dose. Consistent with this, knockdown of the Hes-1 gene, which encodes a critical transcriptional factor in the Notch pathway, also led to the attenuation of ICBP90. On the contrary, Jagged-1, a Notch ligand, facilitated ICBP90 production. Adriamycin could result in the reduction of ICBP90, which was not accompanied with the alteration of Hes-1. ICBP90 was almost fully distributed within the nuclei, but Hes-1 was visible within both the cytoplasm and nuclei. Our novel findings strongly indicate that inactivation of the Notch signaling pathway impedes hepatocellular carcinoma progress via reduction of ICBP90.
📖 Papers frequently viewed together
20187.97Oncogene
16 Citations
6 Authors (Fan Wang, ..., Bin Cheng)
34 Citations
9 Authors (Li Li, ..., Yiyao Liu)
23 Citations
References27
Newest
#1Kun You (Xinxiang Medical University)H-Index: 5
#2Peisheng Sun (Xinxiang Medical University)H-Index: 3
Last. Jianguo Wang (Xinxiang Medical University)H-Index: 5
view all 6 authors...
Abstract Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. Previous studies have reported that the oxidored-nitro domain containing protein 1 (NOR1) is a novel tumor suppressor in several tumors. Recent evidence suggests that NOR1 is strongly expressed in HCC cells. However, its role and mechanism in HCC are unclear. In the current study, Western blot and qPCR detected strong NOR1 mRNA and protein expression in HepG2 and Hep3B cells. After transfection with NOR...
9 CitationsSource
#1Ingrid Espinoza (University of Mississippi)H-Index: 13
#2Lucio Miele (University of Mississippi)H-Index: 47
Notch signaling is an evolutionarily conserved cell signaling pathway involved in cell fate during development, stem cell renewal and differentiation in postnatal tissues. Roles for Notch in carcinogenesis, in the biology of cancer stem cells and tumor angiogenesis have been reported. These features identify Notch as a potential therapeutic target in oncology. Based on the molecular structure of Notch receptor, Notch ligands and Notch activators, a set of Notch pathway inhibitors have been devel...
205 CitationsSource
#1Monjri Shah (UAB: University of Alabama at Birmingham)H-Index: 17
#2Marielba Zerlin (Columbia University)H-Index: 7
Last. Jason D. Wright (Columbia University)H-Index: 72
view all 6 authors...
Ovarian cancer is the most lethal gynecological malignancy in the United States (1). Symptoms of ovarian cancer are subtle and are often missed, resulting in a high percentage of women being diagnosed with advanced-stage disease. While initially chemotherapy-responsive, disease in many women develops resistance to traditional cytotoxic therapy. The Notch pathway functions in cell fate determination and has been implicated in a number of pathological conditions (2). There are four Notch receptors...
18 Citations
#1Michihiro Mori (Kurashiki University of Science and the Arts)H-Index: 3
#2Tomoyuki Miyamoto (Kurashiki University of Science and the Arts)H-Index: 5
Last. Eiji Ohno (Kurashiki University of Science and the Arts)H-Index: 11
view all 11 authors...
Endometrial cancer is one of the most common gynecological malignancies in Japan, where the disease shows an increasing morbidity. However, surgical therapy remains the treatment of choice for endometrial cancers that tend to be insensitive to radiation therapy and chemotherapy. Therefore, novel therapeutic strategies are required. The Notch signaling pathway regulates embryogenesis and cellular development, but deregulated Notch signaling may contribute to tumorigenesis in several cancers. More...
13 CitationsSource
#1Stefano Zanotti (UConn: University of Connecticut)H-Index: 25
#2Ernesto Canalis (UConn: University of Connecticut)H-Index: 107
Notch signaling mediates cell-to-cell interactions that are critical for embryonic development and tissue renewal. In the canonical signaling pathway, the Notch receptor is cleaved following ligand binding, resulting in the release and nuclear translocation of the Notch intracellular domain (NICD). NICD induces gene expression by forming a ternary complex with the DNA binding protein CBF1/Rbp-Jk, Suppressor of Hairless, Lag1, and Mastermind-Like (Maml). Hairy Enhancer of Split (Hes) and Hes rela...
49 CitationsSource
#1Patrick Viatour (Stanford University)H-Index: 22
#2Ursula Ehmer (University of Liège)H-Index: 5
Last. Julien Sage (Stanford University)H-Index: 62
view all 15 authors...
Hepatocellular carcinoma (HCC) is the third cancer killer worldwide with >600,000 deaths every year. Although the major risk factors are known, therapeutic options in patients remain limited in part because of our incomplete understanding of the cellular and molecular mechanisms influencing HCC development. Evidence indicates that the retinoblastoma (RB) pathway is functionally inactivated in most cases of HCC by genetic, epigenetic, and/or viral mechanisms. To investigate the functional relevan...
158 CitationsSource
#1Mahmoud Alhosin (UDS: University of Strasbourg)H-Index: 18
#2Tanveer Sharif (UDS: University of Strasbourg)H-Index: 8
Last. Christian Bronner (UDS: University of Strasbourg)H-Index: 49
view all 7 authors...
Over-expressed in numerous cancers, Ubiquitin-like containing PHD Ring Finger 1 (UHRF1, also known as ICBP90 or Np95) is characterized by a SRA domain (Set and Ring Associated) which is found only in the UHRF family. UHRF1 constitutes a complex with histone deacetylase 1 (HDAC1) and DNA methyltransferase 1 (DNMT1) via its SRA domain and represses the expression of several tumour suppressor genes (TSGs) including p16INK4A, hMLH1, BRCA1 and RB1. Conversely, UHRF1 is regulated by other TSGs such as...
83 CitationsSource
#1Sankaranarayanan Kannan (University of Texas MD Anderson Cancer Center)H-Index: 9
#2Wendy Fang (University of Texas MD Anderson Cancer Center)H-Index: 8
Last. Patrick A. Zweidler-McKay (University of Texas MD Anderson Cancer Center)H-Index: 34
view all 7 authors...
Notch signaling plays both oncogenic and tumor suppressor roles, depending on cell type. In contrast to T-cell acute lymphoblastic leukemia (ALL), where Notch activation promotes leukemogenesis, induction of Notch signaling in B-cell ALL (B-ALL) leads to growth arrest and apoptosis. The Notch target Hairy/Enhancer of Split1 (HES1) is sufficient to reproduce this tumor suppressor phenotype in B-ALL; however, the mechanism is not yet known. We report that HES1 regulates proapoptotic signals by the...
47 CitationsSource
#1Hamed Al-Hussaini (U of T: University of Toronto)H-Index: 1
#2Deepa SubramanyamH-Index: 1
Last. Srikala S. SridharH-Index: 31
view all 4 authors...
The highly conserved Notch signaling pathway is involved in regulating a number of key cellular processes. This pathway has been implicated in both the development and progression of breast cancer and has emerged as a possible therapeutic target. Several clinical trials are currently underway to determine if targeting the Notch pathway with drugs such as the γ-secretase inhibitors may be an effective therapeutic strategy that improves outcomes in this disease. Mol Cancer Ther; 10(1); 9–15. ©2010...
118 CitationsSource
#1Motoko UnokiH-Index: 29
#2Yataro Daigo (UTokyo: University of Tokyo)H-Index: 70
Last. Yusuke Nakamura (UTokyo: University of Tokyo)H-Index: 201
view all 6 authors...
(http://unit.aist.go.jp/riss/crm/exposurefactors/english_summary.html). The 5-year survival rate based on pathologic (p) stages was analysed using a large population of Japanese lung cancer cases (n ¼13010) in 2005 (Asamura et al, 2008). According to the study, the 5-year survival rates of SCLC patients who underwent plumonary resections were as follows: 58.3%, 60.2%, 40.6%, 41.1%, 28.3%, 34.6%, and 30.8% for IA, IB, IIA, IIB, IIIA, IIIB, and IV, respectively. The 5-year survival rates of NSCLC ...
85 CitationsSource
Cited By1
Newest
#1Sandrine Gulberti (University of Lorraine)H-Index: 13
#2Xianqing MaoH-Index: 11
Last. Sylvie Fournel-Gigleux (University of Lorraine)H-Index: 27
view all 4 authors...
Abstract Heparan-sulfate modifications are master regulators of the cross-talk between cell and matrix and modulate the biological activity of an array of HS binding proteins, including growth factors and chemokines, morphogens and immunity cell receptors. This review will highlight the importance of HS maturation mediated by N-deactetylase/sulfotransferases, 2- and 6O-sulfotransferases in cancer biology, and will focus on the 3O-sulfotransferases and on the terminal, rare 3O-sulfation, and thei...
7 CitationsSource